Morning Overview on MSN
RNA strand that nearly self-replicates could unlock life’s origin
A 45-nucleotide strand of RNA can now synthesize both its mirror-image complement and a copy of itself, bringing scientists ...
Pharmaceutical Technology on MSN
RNA-targeting small molecules: A new frontier of drug discovery
With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology ...
Although there are striking differences between the cells that make up your eyes, kidneys, brain and toes, the DNA blueprint ...
While you’re probably pretty familiar with DNA, it’s likely that RNA only made it onto your radar during the pandemic, thanks to Covid-19 vaccines such as the ones from Moderna and Pfizer. DNA is “the ...
This webinar will highlight how circular RNA overcomes key challenges in in vivo CAR-T therapy, with case examples from YXgene’s circRNA platform. In vivo CAR-T therapy is emerging as a transformative ...
When a neuron in our body gets damaged, segments of RNA produce proteins that can help repair the injury. But in neurological disorders such as ALS and spinal muscular atrophy, or following spinal ...
Johns Hopkins University, home to considerable expertise in RNA sciences and therapeutic development, has announced a new academic collaboration with TriLink BioTechnologies, part of Maravai ...
COVID proved the therapeutic potential of RNA technology – making it more available is the next goal
This work was supported by funding from New Zealand Ministry of Business Innovation and Employment, Research Trust of Victoria University of Wellington and The Hugh Green Foundation. The recent award ...
Molecular Instruments® (MI), inventor of the HCR™ technology, today announced the availability of fully ambient-temperature HCR™ Pro RNA-ISH on the BOND-III, introducing a new class of clinical-grade ...
According to Precedence Research, the global RNA analysis market size is expected to be worth USD 23.39 billion by 2035, increasing from USD 10.21 billion in 2026, with a strong CAGR of 9.65% from ...
Penn Commons at the University of Pennsylvania (Mark Henninger/Imagic Digital) Cellular-level biology that could help develop vaccines just got more accessible to researchers, thanks to AI. The ...
Researchers engineered RNA micelles carrying gemcitabine, survivin-targeting siRNA and a tumor-binding ligand. In mice with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results